共 48 条
[26]
Safety, tolerability, pharmacodynamics and pharmacokinetics following once-daily doses of BI 187004, an inhibitor of 11 beta-hydroxysteroid dehydrogenase-1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity
[J].
DIABETES OBESITY & METABOLISM,
2023, 25 (03)
:832-843